Alnylam Pharmaceuticals, Inc. (0HD2.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:38PM BST
| Previous close | 153.03 |
| Open | 151.01 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 151.01 - 155.30 |
| 52-week range | 143.66 - 217.98 |
| Volume | |
| Avg. volume | 1,441 |
| Market cap | 177.163M |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.49 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ALNY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
ZacksAlnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
Simply Wall St.Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) First Quarter 2024 Results Key Financial Results Revenue: US$494.3m (up 55...
© 2024 Yahoo. All rights reserved.